Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

INTRODUCTION: Immune checkpoint inhibitor-related pneumonitis (ICIP) is a potentially life threatening immune-related adverse event (irAE), especially in non-small cell lung cancer (NSCLC) patients. Currently, the potential for increased irAE in patients who receive radiotherapy is scarcely known, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrón, Feliciano, Sánchez, Roberto, Arroyo-Hernández, Marisol, Blanco, Carolina, Zatarain-Barrón, Zyanya L., Catalán, Rodrigo, Ramos-Ramírez, Maritza, Cardona, Andrés F., Flores-Estrada, Diana, Arrieta, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550759/
https://www.ncbi.nlm.nih.gov/pubmed/33117699
http://dx.doi.org/10.3389/fonc.2020.570233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550759/
https://www.ncbi.nlm.nih.gov/pubmed/33117699
http://dx.doi.org/10.3389/fonc.2020.570233

Ejemplares similares